Upregulation of elafin and cystatin C in the ethmoid sinus mucosa of patients with chronic sinusitis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 8, 2009, Pages 771-775

  Lee, Chang Whan ^a   Kim, Tae Hoon ^a   Lee, Heung Man ^a   Lee, Seung Hoon ^a   Lee, Sung Ho ^a   Yoo, Joon Hyuk ^a   Kim, Yeon Soo ^a   Lee, Sang Hag ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; ELAFIN; MESSENGER RNA; PROTEIN;

ADULT; ARTICLE; BLOWOUT FRACTURE; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ENDOSCOPIC SURGERY; ETHMOID SINUS; FEMALE; GOBLET CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE SURGERY; NUCLEOTIDE SEQUENCE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; UPREGULATION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CHRONIC DISEASE; CYSTATIN C; ELAFIN; ENDOSCOPY; ETHMOID SINUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NASAL MUCOSA; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SINUSITIS; UP-REGULATION;

EID: 68949147017     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.97     Document Type: Article

References (22)

1. Ooi EH, Wormald PJ, Tan LW. Innate immunity in the paranasal sinuses: a review of nasal host defenses. Am J Rhinol. 2008;22(1):13-19.
2. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun. 1999;67(7):3267-3275.
3. Lee SH, Lim HH, Lee HM, Choi JO. Expression of human β-defensin 1 mRNA in human nasal mucosa. Acta Otolaryngol. 2000;120(1):58-61.
4. Lee SH, Kim JE, Lim HH, Lee HM, Choi JO. Antimicrobial defensin peptides of the human nasal mucosa. Ann Otol Rhinol Laryngol. 2002;111(2):135-141.
5. Kim ST, Cha HE, Kim DY, et al. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol. 2003;123(1):81-85.
6. Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol. 2007;23(4):370-378.
7. Williams SE, Brown TI, Roghanian A, Sallenave JM. SLPI and elafin: one glove, many fingers. Clin Sci (Lond). 2006;110(1):21-35.
8. Hiemstra PS. Epithelial antimicrobial peptides and proteins: their role in host defence and inflammation. Paediatr Respir Rev. 2001;2(4):306-310.
9. Chapman HA Jr, Reilly JJ Jr, Yee R, Grubb A. Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis. 1990;141(3):698-705.
10. Warfel AH, Cardozo C, Yoo OH, Zucker-Franklin D. Cystatin C and cathepsin B production by alveolar macrophages from smokers and nonsmokers. J Leukoc Biol. 1991;49(1):41-47.
11. Dallegri F, Ottonello L. Tissue injury in neutrophilic inflammation. Inflamm Res. 1997;46(10):382-391.
12. Fukuda K, Itoh K, Ooyama T. A protease inhibitor from human allergic nasal secretions. Acta Otolaryngol. 1987;104(5-6):539-544.
13. Sallenave JM. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir Res. 2000;1(2):87-92.
14. Suzuki Y, Furukawa M, Abe J, Kashiwagi M, Hirose S. Localization of porcine trappin-2 (SKALP/elafin) in trachea and large intestine by in situ hybridization and immunohistochemistry. Histochem Cell Biol. 2000;114(1):15-20.
15. Abrahamson M, Alvarez-Fernadez M, Nathanson CM. Cystatins. Biochem Soc Symp. 2003;70:179-199.
16. Abrahamson M, Barrett DJ, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine: their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem. 1986;261(24): 11282-11289.
17. Schenkels LC, Veerman EC, Nieuw Amerongen AV. Biochemical composition of human saliva in relation to other mucosal fluids. Crit Rev Oral Biol Med. 1995; 6(2):161-175.
18. Hopsu-Havu V, Järvinen M, Rinne A. Separation of cysteine proteinase inhibitors from psoriatic scale. Br J Dermatol. 1983;109(suppl 25):77-85.
19. Ichimaru E, Imura K, Hara Y, Kato Y, Kato I. Cystatin activity in gingival crevicular fluid from periodontal disease patients measured by a new quantitative analysis method. J Periodontal Res. 1992;27(2):119-125.
20. Buttle DJ, Burnett D, Abrahamson M. Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum, relationship to inflammation. Scand J Clin Lab Invest. 1990;50(5):509-516.
21. Nagai A, Terashima M, Harada T, et al. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis. Clin Chim Acta. 2003;329(1-2):53-60.
22. Chu SC, Wang CP, Chang YH, et al. Increased cystatin C serum concentrations in patients with hepatic diseases of various severities. Clin Chim Acta. 2004; 341(1-2):133-138.